December 26, 2014 – On November 12th and 13th,2014, The Montreal Neurological Institute and Hospital hosted the 3rd International Symposium focusing on advances in understanding ARSACS (Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay) in the larger context of mitochondrial dysfunction in neurodegeneration. This two day symposium, sponsored by the Ataxia of Charlevoix-Saguenay Foundation and CIHR Institute of Genetics New Emerging Team on ARSACS, brought together clinical, ataxia, mitochondrial experts from different countries and drug developers to discuss how to accelerate the discovery of treatments for ARSACS. Several experts in the field shared their knowledge and experience on the subject.See Symposium program.


Short video of the panel discussions on ARSACS at the Café scientifique held in November 2014.Panel discussions